PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-16.26%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-26.53%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
22.34%
Positive EBIT growth while ADI is negative. John Neff might see a substantial edge in operational management.
-80.00%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-84.11%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-88.89%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-88.89%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.47%
Share reduction while ADI is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.62%
Reduced diluted shares while ADI is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.47%
Dividend growth above 1.5x ADI's 0.23%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-77.55%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-80.02%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
28.28%
10Y revenue/share CAGR under 50% of ADI's 62.85%. Michael Burry would suspect a lasting competitive disadvantage.
-3.43%
Negative 5Y CAGR while ADI stands at 0.59%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-22.22%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
45.03%
10Y OCF/share CAGR above 1.5x ADI's 5.34%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-13.19%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-43.98%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-91.64%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-93.70%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-96.39%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
72.90%
10Y equity/share CAGR at 50-75% of ADI's 111.50%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
3.59%
Positive 5Y equity/share CAGR while ADI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
1.88%
Positive short-term equity growth while ADI is negative. John Neff sees a strong advantage in near-term net worth buildup.
435.74%
Dividend/share CAGR of 435.74% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
417.97%
Similar 5Y dividend/share CAGR to ADI's 400.44%. Walter Schloss sees parallel philosophies in mid-term capital returns.
265.17%
3Y dividend/share CAGR above 1.5x ADI's 66.07%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
23.22%
Our AR growth while ADI is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-20.15%
Inventory is declining while ADI stands at 2.01%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-3.38%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-0.78%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
No Data
No Data available this quarter, please select a different quarter.
-10.44%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-15.75%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.